Cargando…
Cost‐effectiveness of pancreas surveillance: The CDKN2A‐p16‐Leiden cohort
BACKGROUND: CDKN2A‐p16‐Leiden mutation carriers have a high lifetime risk of developing pancreatic ductal adenocarcinoma (PDAC), with very poor survival. Surveillance may improve prognosis. OBJECTIVE: To assess the cost‐effectiveness of surveillance, as compared to no surveillance. METHODS: In 2000,...
Autores principales: | Ibrahim, Isaura S., Vasen, Hans F. A., Wasser, Martin N. J. M., Feshtali, Shirin, Bonsing, Bert A., Morreau, Hans, Inderson, Akin, de Vos tot Nederveen Cappel, Wouter H., van den Hout, Wilbert B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10039795/ https://www.ncbi.nlm.nih.gov/pubmed/36785917 http://dx.doi.org/10.1002/ueg2.12360 |
Ejemplares similares
-
Incidental findings in pancreas screening programs for high-risk individuals: Results from three European expert centers
por: Ibrahim, Isaura S, et al.
Publicado: (2019) -
Dilemmas in the management of screen-detected lesions in patients at high risk for pancreatic cancer
por: Ibrahim, Isaura S., et al.
Publicado: (2016) -
Prophylactic total pancreatectomy in individuals at high risk of pancreatic ductal adenocarcinoma (PROPAN): systematic review and shared decision-making programme using decision tables
por: Scholten, Lianne, et al.
Publicado: (2020) -
Fibroblast drug scavenging increases intratumoural gemcitabine accumulation in murine pancreas cancer
por: Hessmann, E, et al.
Publicado: (2018) -
Surgical diseases of the pancreas /
Publicado: (1960)